Professor Mark Morrison
Professor

Mark Morrison

Email: 
Phone: 
+61 7 344 36957

Availability

Professor Mark Morrison is:
Available for supervision

Fields of research

Biomedical and Clinical Sciences Clinical microbiology Clinical sciences Gastroenterology and hepatology Medical biochemistry and metabolomics Medical microbiology

Qualifications

  • Bachelor of Science, University of New South Wales
  • Masters (Research) of Science, James Cook University
  • Doctor of Philosophy, University of Illinois

Search Professor Mark Morrison’s works on UQ eSpace

366 works between 1990 and 2024
All (366) Journal Article (229) Book Chapter (7) Conference Publication (130)

41 - 60 of 366 works

2023

Journal Article

Isolation and characterisation of novel Methanocorpusculum species indicates the genus is ancestrally host-associated

Volmer, James G., Soo, Rochelle M., Evans, Paul N., Hoedt, Emily C., Astorga Alsina, Ana L., Woodcroft, Benjamin J., Tyson, Gene W., Hugenholtz, Philip and Morrison, Mark (2023). Isolation and characterisation of novel Methanocorpusculum species indicates the genus is ancestrally host-associated. BMC Biology, 21 (1) 59, 1-17. doi: 10.1186/s12915-023-01524-2

Isolation and characterisation of novel Methanocorpusculum species indicates the genus is ancestrally host-associated

2023

Journal Article

Maternal diet modulates the infant microbiome and intestinal Flt3L necessary for dendritic cell development and immunity to respiratory infection

Sikder, Md. Al Amin, Rashid, Ridwan B., Ahmed, Tufael, Sebina, Ismail, Howard, Daniel R., Ullah, Md. Ashik, Rahman, Muhammed Mahfuzur, Lynch, Jason P., Curren, Bodie, Werder, Rhiannon B., Simpson, Jennifer, Bissell, Alec, Morrison, Mark, Walpole, Carina, Radford, Kristen J., Kumar, Vinod, Woodruff, Trent M., Ying, Tan Hui, Ali, Ayesha, Kaiko, Gerard E., Upham, John W., Hoelzle, Robert D., Cuív, Páraic Ó., Holt, Patrick G., Dennis, Paul G. and Phipps, Simon (2023). Maternal diet modulates the infant microbiome and intestinal Flt3L necessary for dendritic cell development and immunity to respiratory infection. Immunity, 56 (5), 1098-1114.e10. doi: 10.1016/j.immuni.2023.03.002

Maternal diet modulates the infant microbiome and intestinal Flt3L necessary for dendritic cell development and immunity to respiratory infection

2023

Journal Article

Effect of food additives on key bacterial taxa and the mucosa-associated microbiota in Crohn’s disease. The ENIGMA study

Loayza, J.J. Jimenez, Kang, S., Schooth, L., Teh, J. J., de Klerk, A., Noon, E. K., Zhang, J., Hu, J., Hamilton, A. L., Wilson-O’Brien, A., Trakman, G. L., Lin, W., Ching, J., Or, L., Sung, J.J.Y., Yu, J., Ng, S.C., Kamm, M.A. and Morrison, M. (2023). Effect of food additives on key bacterial taxa and the mucosa-associated microbiota in Crohn’s disease. The ENIGMA study. Gut Microbes, 15 (1) 2172670, 1-18. doi: 10.1080/19490976.2023.2172670

Effect of food additives on key bacterial taxa and the mucosa-associated microbiota in Crohn’s disease. The ENIGMA study

2023

Conference Publication

Key anti-inflammatory Faecalibacterium prausnitzii is heterogeneous and diverse in the East and West and in health and Crohn’s disease. The ENIGMA study

Teh, J. J., Kang, S., Leonard, A., Zhang, J., Hu, J., Hamilton, A. L., Wilson-O'Brien, A., Trakman, G. L., Lin, W., Ching, J., Sung, J. J. Y., Yu, J., Ng, S. C., Kamm, M. A. and Morrison, M. (2023). Key anti-inflammatory Faecalibacterium prausnitzii is heterogeneous and diverse in the East and West and in health and Crohn’s disease. The ENIGMA study. 18th Congress of ECCO, Copenhagen, Denmark, 1-4 March 2023. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ecco-jcc/jjac190.0088

Key anti-inflammatory Faecalibacterium prausnitzii is heterogeneous and diverse in the East and West and in health and Crohn’s disease. The ENIGMA study

2023

Conference Publication

Deep functional assessment of the colonic mucosa-associated microbiota in Crohn's disease and health identifies pro- and anti- inflammatory secretomes and associated bacterial consortia. The ENIGMA study

Teh, J. J., Kang, S., Zhang, J., Hu, J., Hamilton, A. L., Wilson-O'Brien, A., Trakman, G. L., Lin, W., Ching, J., Sung, J. J. Y., Yu, J., Ng, S. C., Kamm, M. A. and Morrison, M. (2023). Deep functional assessment of the colonic mucosa-associated microbiota in Crohn's disease and health identifies pro- and anti- inflammatory secretomes and associated bacterial consortia. The ENIGMA study. 18th Congress of ECCO, Copenhagen, Denmark, 1-4 March 2023. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ecco-jcc/jjac190.1055

Deep functional assessment of the colonic mucosa-associated microbiota in Crohn's disease and health identifies pro- and anti- inflammatory secretomes and associated bacterial consortia. The ENIGMA study

2023

Conference Publication

Metagenomic characterisation of the colonic mucosa-associated microbiota reveals novel microbes and communities in health and Crohn’s disease. The ENIGMA study

Kang, S., Teh, J. J., Zhang, J., Hu, J., Hamilton, A. L., Wilson-O'Brien, A., Trakman, G. L., Lin, W., Ching, J., Sung, J. J. Y., Yu, J., Ng, S. C., Kamm, M. A. and Morrison, M. (2023). Metagenomic characterisation of the colonic mucosa-associated microbiota reveals novel microbes and communities in health and Crohn’s disease. The ENIGMA study. 18th Congress of ECCO, Copenhagen, Denmark, 1-4 March 2023. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ecco-jcc/jjac190.0089

Metagenomic characterisation of the colonic mucosa-associated microbiota reveals novel microbes and communities in health and Crohn’s disease. The ENIGMA study

2023

Journal Article

Characteristics of the gastrointestinal microbiota following prebiotic supplementation in acute kidney transplant recipients: Results from a randomised controlled trial

Chan, Samuel, Wood, David LA, Hawley, Carmel M., Campbell, Katrina L., Campbell, Scott B., Cao, Christopher, Francis, Ross S., Hale, Rachael, Isbel, Nicole M., Pascoe, Elaine M., Johnson, David W. and Morrison, Mark (2023). Characteristics of the gastrointestinal microbiota following prebiotic supplementation in acute kidney transplant recipients: Results from a randomised controlled trial. Clinical Transplantation, 38 (1) e15175, e15175. doi: 10.1111/ctr.15175

Characteristics of the gastrointestinal microbiota following prebiotic supplementation in acute kidney transplant recipients: Results from a randomised controlled trial

2022

Journal Article

Exercise‐induced changes to the human gut microbiota and implications for colorectal cancer: A narrative review

Boytar, Alexander N., Nitert, Marloes Dekker, Morrision, Mark, Skinner, Tina L. and Jenkins, David G. (2022). Exercise‐induced changes to the human gut microbiota and implications for colorectal cancer: A narrative review. The Journal of Physiology, 600 (24), 5189-5201. doi: 10.1113/jp283702

Exercise‐induced changes to the human gut microbiota and implications for colorectal cancer: A narrative review

2022

Journal Article

Evaluation of co-circulating pathogens and microbiome from COVID-19 infections

Thissen, James B., Morrison, Michael D., Mulakken, Nisha, Nelson, William C., Daum, Chris, Messenger, Sharon, Wadford, Debra A. and Jaing, Crystal (2022). Evaluation of co-circulating pathogens and microbiome from COVID-19 infections. PLoS One, 17 (12) e0278543, 1-20. doi: 10.1371/journal.pone.0278543

Evaluation of co-circulating pathogens and microbiome from COVID-19 infections

2022

Journal Article

Distinctive gut microbiomes of ankylosing spondylitis and inflammatory bowel disease patients suggest differing roles in pathogenesis and correlate with disease activity

Sternes, P. R., Brett, L., Phipps, J., Ciccia, F., Kenna, T., de Guzman, E., Zimmermann, K., Morrison, M., Holtmann, G., Klingberg, E., Mauro, D., McIvor, C., Forsblad-d’Elia, H. and Brown, M. A. (2022). Distinctive gut microbiomes of ankylosing spondylitis and inflammatory bowel disease patients suggest differing roles in pathogenesis and correlate with disease activity. Arthritis Research and Therapy, 24 (1) 163, 1-10. doi: 10.1186/s13075-022-02853-3

Distinctive gut microbiomes of ankylosing spondylitis and inflammatory bowel disease patients suggest differing roles in pathogenesis and correlate with disease activity

2022

Journal Article

The duodenal mucosa associated microbiome, visceral sensory function, immune activation and psychological comorbidities in functional gastrointestinal disorders with and without self-reported non-celiac wheat sensitivity

Shah, Ayesha, Kang, Seungha, Talley, Nicholas J., Do, Anh, Walker, Marjorie M., Shanahan, Erin R., Koloski, Natasha A., Jones, Michael P., Keely, Simon, Morrison, Mark and Holtmann, Gerald J. (2022). The duodenal mucosa associated microbiome, visceral sensory function, immune activation and psychological comorbidities in functional gastrointestinal disorders with and without self-reported non-celiac wheat sensitivity. Gut Microbes, 14 (1) 2132078, 1-21. doi: 10.1080/19490976.2022.2132078

The duodenal mucosa associated microbiome, visceral sensory function, immune activation and psychological comorbidities in functional gastrointestinal disorders with and without self-reported non-celiac wheat sensitivity

2022

Journal Article

How frequent are vancomycin-resistant enterococci in patients with primary sclerosing cholangitis and ulcerative colitis treated with oral vancomycin?

Shah, Ayesha, Pakneeshan, Sahar, Jones, Michael P., Koloski, Natasha, Callaghan, Gavin, Morrison, Mark and Holtmann, Gerald (2022). How frequent are vancomycin-resistant enterococci in patients with primary sclerosing cholangitis and ulcerative colitis treated with oral vancomycin?. Indian Journal of Gastroenterology, 41 (5), 519-524. doi: 10.1007/s12664-022-01286-9

How frequent are vancomycin-resistant enterococci in patients with primary sclerosing cholangitis and ulcerative colitis treated with oral vancomycin?

2022

Journal Article

Processed food as a risk factor for the development and perpetuation of Crohn’s Disease—the ENIGMA study

Trakman, Gina L., Lin, Winnie Y. Y., Hamilton, Amy L., Wilson-O’Brien, Amy L., Stanley, Annalise, Ching, Jessica Y., Yu, Jun, Mak, Joyce W. Y., Sun, Yang, Niu, Junkun, Miao, Yinglei, Lin, Xiaoqing, Feng, Rui, Chen, Minhu, Shivappa, Nitin, Hebert, James R., Morrison, Mark, Ng, Siew C. and Kamm, Michael A (2022). Processed food as a risk factor for the development and perpetuation of Crohn’s Disease—the ENIGMA study. Nutrients, 14 (17) 3627, 1-23. doi: 10.3390/nu14173627

Processed food as a risk factor for the development and perpetuation of Crohn’s Disease—the ENIGMA study

2022

Conference Publication

Deep metagenomic sequencing of the colonic mucosa-associated microbiota shows novel microbes and transnational differences in health and Crohn's disease: The ENIGMA study

Teh, J. J., Kang, S., Zhang, J., Hu, J., Hamilton, A., Wilson-O'Brien, A., Ching, J. Y. L., Lin, W., Trakman, G., Sung, J., Jun, Y., Ng, S., Kamm, M. and Morrison, M. (2022). Deep metagenomic sequencing of the colonic mucosa-associated microbiota shows novel microbes and transnational differences in health and Crohn's disease: The ENIGMA study. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2022, Sydney, NSW Australia, 9–11 September 2022. Richmond, VIC Australia: John Wiley & Sons.

Deep metagenomic sequencing of the colonic mucosa-associated microbiota shows novel microbes and transnational differences in health and Crohn's disease: The ENIGMA study

2022

Conference Publication

The food additive carrageenan has differential effects on the growth of the mucosa-associated microbiota from Asian and Western people with Crohn's disease and healthy controls: The ENIGMA study

Kang, S., Teh, J. J., Schooth, L., Zhang, J., Hu, J., Hamilton, A. L., Wilson-O'Brien, A., Ching, J. Y. L., Lin, W., Trakman, G. L., Sung, J., Yu, J., Ng, S. C., Kamm, M. A. and Morrison, M. (2022). The food additive carrageenan has differential effects on the growth of the mucosa-associated microbiota from Asian and Western people with Crohn's disease and healthy controls: The ENIGMA study. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2022, Sydney, NSW Australia, 9–11 September 2022. Richmond, VIC Australia: John Wiley & Sons.

The food additive carrageenan has differential effects on the growth of the mucosa-associated microbiota from Asian and Western people with Crohn's disease and healthy controls: The ENIGMA study

2022

Conference Publication

Elevated artificial sweetener levels are associated with Crohn's disease: The ENIGMA study

Hu, J., Ruan, Y., Lin, W., Trakman, G., Zhang, J., Teh, J. J., Kang, S., Hamilton, A., Wilson-O'Brien, A., Ching, J. Y. L., Sung, J. J. Y., Yu, J., Morrison, M., Kamm, M. A. and Ng, S. C. (2022). Elevated artificial sweetener levels are associated with Crohn's disease: The ENIGMA study. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2022, Sydney, NSW Australia, 9–11 September 2022. Richmond, VIC Australia: John Wiley & Sons.

Elevated artificial sweetener levels are associated with Crohn's disease: The ENIGMA study

2022

Conference Publication

Diversity of Veillonella in cultures of the duodenal mucosa-associated microbiota suggests species-level differences between people with and without functional gastrointestinal symptoms

Schooth, L., Sid-Ahmed, A., Kang, S., Lim, Y., Fairlie, T., Shah, A., Holtmann, G. and Morrison, M. (2022). Diversity of Veillonella in cultures of the duodenal mucosa-associated microbiota suggests species-level differences between people with and without functional gastrointestinal symptoms. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2022, Sydney, NSW Australia, 9–11 September 2022. Richmond, VIC Australia: John Wiley & Sons.

Diversity of Veillonella in cultures of the duodenal mucosa-associated microbiota suggests species-level differences between people with and without functional gastrointestinal symptoms

2022

Journal Article

Cross‐sectional and longitudinal associations between gut microbiota composition and cognition in the second year of life: findings from the Child Health and Resident Microbes study

Matsuyama, Misa, Murtaza, Nida, Morrison, Mark, Davies, Peter S. W., Hill, Rebecca J. and Loughman, Amy (2022). Cross‐sectional and longitudinal associations between gut microbiota composition and cognition in the second year of life: findings from the Child Health and Resident Microbes study. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 189 (7-8), 285-292. doi: 10.1002/ajmg.b.32915

Cross‐sectional and longitudinal associations between gut microbiota composition and cognition in the second year of life: findings from the Child Health and Resident Microbes study

2022

Journal Article

Links between celiac disease and small intestinal bacterial overgrowth: A systematic review and meta‐analysis

Shah, Ayesha, Thite, Parag, Hansen, Teressa, Kendall, Bradley J., Sanders, David S., Morrison, Mark, Jones, Michael P. and Holtmann, Gerald (2022). Links between celiac disease and small intestinal bacterial overgrowth: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology, 37 (10), 1844-1852. doi: 10.1111/jgh.15920

Links between celiac disease and small intestinal bacterial overgrowth: A systematic review and meta‐analysis

2022

Journal Article

Childhood antibiotics as a risk factor for Crohn's disease: The ENIGMA International Cohort Study

Mak, Joyce W. Y., Yang, Sun, Stanley, Annalise, Lin, Xiaoqing, Morrison, Mark, Ching, Jessica Y. L., Niu, Junkun, Wilson-O'Brien, Amy L., Feng, Rui, Tang, Whitney, Hamilton, Amy L., Or, Leo, Trakman, Gina L., Lin, Winnie Y. Y., Sung, Joseph J. Y., Chen, Ming Hu, Mao, Yinglei, Kamm, Michael A. and Ng, Siew C. (2022). Childhood antibiotics as a risk factor for Crohn's disease: The ENIGMA International Cohort Study. JGH Open, 6 (6), 369-377. doi: 10.1002/jgh3.12755

Childhood antibiotics as a risk factor for Crohn's disease: The ENIGMA International Cohort Study

Current funding

  • 2024 - 2025
    Onco-Derm: a single site prospective analysis of skin microbiome as a predictor of toxicity in patients receiving immune checkpoint inhibitor therapy
    Microba Pty Ltd
    Open grant
  • 2024 - 2027
    Harnessing microbial immunomodulatory function to improve treatment of inflammatory bowel diseases
    NHMRC IDEAS Grants
    Open grant
  • 2023 - 2025
    Investigating gastrointestinal biofilms regarding biochemistry and links with clinical manifestations (2023 MSHRSS Co-funded Collaboration Grant led by MSH)
    Metro South Research Support Scheme Co-funded Collaboration Grant
    Open grant
  • 2022 - 2025
    Defining host immune and microbial determinants of disease trajectory in mycobacterial infection
    Metro South Hospital and Health Service
    Open grant
  • 2022 - 2026
    Microbiome Manipulation to Treat and Cure Inflammatory Bowel Disease (NHMRC Investigator Grant led by CI Kamm University of Melbourne)
    University of Melbourne
    Open grant
  • 2021 - 2024
    Drugs from Bugs: Developing New Inflammatory Bowel Disease Drugs from Gut Bacteria-Derived Bioactives
    United States Congressionally Directed Medical Research Programs - Peer Reviewed Medical Research Program
    Open grant
  • 2021 - 2024
    Bringing Archaeal biodiversity to life from native Australian herbivores
    ARC Discovery Projects
    Open grant
  • 2020 - 2025
    Creating an evidence base for clinical care: A randomized controlled study examining the efficacy of the low FODMAP diet for... (MRFF EPCDR Endometriosis Grant led by Monash)
    Monash University
    Open grant
  • 2020 - 2025
    Targeting the gut microbiome as a treatment for Primary Sclerosing Cholangitis: The Queensland Clinical Network Study
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2019 - 2024
    Centre for Research Excellence in Digestive Health (NHMRC CRE administered by University of Newcastle)
    University of Newcastle
    Open grant

Past funding

  • 2023 - 2024
    Responses of duodenal spheroid cultures to the secretomes of duodenal microbiota from patients with and without disorders of gut brain interactions (NHMRC CRE led by University of Newcastle)
    University of Newcastle
    Open grant
  • 2022 - 2023
    The effects of variable doses of STW 5 and STW 5-II on bacterial isolates from the duodenum and the duodenal mucosa-associated microbiomes from subjects with and without functional GI symptoms
    Bayer - Steigerwald Arzneimittelwerk GmbH
    Open grant
  • 2022
    Linking the presence of live Ileal-derived bacteria in the joint as a triggering factor for the development of Spondyloarthropathy.
    Arthritis Foundation of Australia
    Open grant
  • 2021 - 2022
    Impacts of food additives on the duodenal mucosa-associated microbiota
    University of Newcastle
    Open grant
  • 2020 - 2024
    Modulation of the Gastrointestinal Microbiome with probiotics and subsequent Methane production as a novel approach to treat constipation: A Proof of Principle Study (TRI Sport Grant led by PAH)
    Metro South Hospital and Health Service
    Open grant
  • 2020 - 2021
    Comparative Genomic Sequencing of selected strains of probiotic bacteria - Phase II
    Innovation Connections
    Open grant
  • 2020 - 2021
    Functionally characterizing IBD dysbiosis and harnessing gut bioactives to suppress IL-23 driven inflammation
    The Global Grants for Gut Health
    Open grant
  • 2019 - 2020
    Comparative Genomic Sequencing of selected strains of probiotic bacteria
    Innovation Connections
    Open grant
  • 2017 - 2020
    Invention of a Genetic Toolkit for Immunomodulatory Gut Bacteria to Expedite the Development of New Crohn's Disease Therapeutics
    United States Congressionally Directed Medical Research Programs - Peer Reviewed Medical Research Program
    Open grant
  • 2017 - 2018
    Prebiotic Study of Faecal Samples - Using Diets Rich in Dietary Fibre to Improve Bowel Habit and Sense of Wellbeing
    Monash University
    Open grant
  • 2017 - 2022
    The ENIGMA project: Eastern Inflammatory Bowel Disease Gut Microbiota
    Australasian Gastro Intestinal Research Foundation
    Open grant
  • 2017 - 2020
    Epithelial metabolism as a mediator of host-microbiome interactions in inflammatory bowel disease (NHMRC Project Grant administered by The University of Newcastle)
    University of Newcastle
    Open grant
  • 2017 - 2018
    Linking maternal and infant microbiome: effects of GDM or effects of probiotics?
    Diabetes Australia Research Program
    Open grant
  • 2016 - 2019
    Rapid functional and taxonomic skin microbe characterisation
    ARC Linkage Projects
    Open grant
  • 2016 - 2020
    Design rules for nutritionally-functional grains
    ARC Linkage Projects
    Open grant
  • 2016
    Establishing a gnotobiotic germ-free mouse facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    Instrumentation for the analysis of cellular and metabolic phenotypes
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    Modification of the microbiome to protect against spondyloarthropathy in SKG mice
    Arthritis Foundation of Australia
    Open grant
  • 2016
    The Australian human microbiota project-microbe isolation facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015 - 2017
    Microbiome in highly trained athletes and response to dietary change
    Australian Institute Sport
    Open grant
  • 2015
    Design rules for nutritionally-functional starches
    UQ Collaboration and Industry Engagement Fund - Seed Research Grant
    Open grant
  • 2015 - 2017
    Evolution of the marsupial gut microbiome and adaptation to eucalypt toxins
    ARC Discovery Projects
    Open grant
  • 2015 - 2018
    Pathophysiology of functional dyspepsia: Integration of upper gut function, inflammation and a systems biology approach.
    NHMRC Project Grant
    Open grant
  • 2015 - 2016
    Your microbiome or your mother's? The relationship between the microbiomes of mothers and babies
    Royal Brisbane and Women's Hospital
    Open grant
  • 2014 - 2017
    Interactions between host and the gut microbiome in the pathogenesis of ankylosing spondylitis and Crohn's disease
    NHMRC Project Grant
    Open grant
  • 2014 - 2015
    Bringing genomes to life: isolation of genetically tractable, not-yet-cultured members of the human microbiota using metaparental mating methods
    PA Research Foundation
    Open grant
  • 2014 - 2018
    Determinants of progression of actinic keratoses to squamous cancer
    NHMRC Project Grant
    Open grant

Availability

Professor Mark Morrison is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Enquiries

For media enquiries about Professor Mark Morrison's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au